Top takeaways from ASCO: Advanced squamous cell carcinoma of the head and neck

Data from two high-profile trials presented at the ASCO Annual Meeting assessed treatment options and quality of life for patients with advanced head and neck squamous cell carcinoma. Two HemOnc Today Editorial Board members discussed the take-home messages and long-term implications of these findings.

HemOnc Today